RHY 4.11% 7.0¢ rhythm biosciences limited

Rhy: Proxy forms., page-15

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    Perhaps you should apply for the CEO role? Your expertise regarding what should have been done and when is very impressive, I can only imagine the perfect decisions you might bring forth for the company. Disruptive technology usually follows a fairly standard development process right? Oh, and following the immediate successful commercialisation of Colostat under your direction, you'd require absolutely no personal financial reward, therefore agreeing to never sell
    a single of your own shares.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.